Marta Valenciano

Summary

Publications

  1. doi The European I-MOVE Multicentre 2013-2014 Case-Control Study. Homogeneous moderate influenza vaccine effectiveness against A(H1N1)pdm09 and heterogenous results by country against A(H3N2)
    Marta Valenciano
    Epidemiology Department, EpiConcept, Paris, France Electronic address
    Vaccine 33:2813-22. 2015
  2. ncbi Early estimates of seasonal influenza vaccine effectiveness in Europe: results from the I-MOVE multicentre case-control study, 2012/13
    M Valenciano
    EpiConcept, Paris, France
    Euro Surveill 18:3. 2013
  3. doi Study designs for timely estimation of influenza vaccine effectiveness using European sentinel practitioner networks
    Marta Valenciano
    EpiConcept, Paris, France
    Vaccine 28:7381-8. 2010
  4. pmc Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-2010: results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) multicentre case-control study
    Marta Valenciano
    EpiConcept, Paris, France
    PLoS Med 8:e1000388. 2011
  5. pmc I-MOVE multi-centre case control study 2010-11: overall and stratified estimates of influenza vaccine effectiveness in Europe
    Esther Kissling
    EpiConcept, Paris, France
    PLoS ONE 6:e27622. 2011

Collaborators

  • Jean Marie Cohen
  • Caterina Rizzo
  • Piotr Kramarz
  • Camelia Savulescu
  • Esther Kissling
  • Iwona Anna Paradowska-Stankiewicz
  • Thomas Seyler
  • Isabelle Daviaud
  • Beatrix Oroszi
  • Silvia Jimenez-Jorge
  • Bruno Christian Ciancio
  • Pawel Stefanoff
  • Alina Elena Ivanciuc
  • Pedro Pechirra
  • Joan O'Donnell
  • Alain Moren
  • Amparo Larrauri
  • Baltazar Nunes
  • Judit Krisztina Horvath
  • Anne Sophie Barret
  • Daniela Pitigoi

Detail Information

Publications5

  1. doi The European I-MOVE Multicentre 2013-2014 Case-Control Study. Homogeneous moderate influenza vaccine effectiveness against A(H1N1)pdm09 and heterogenous results by country against A(H3N2)
    Marta Valenciano
    Epidemiology Department, EpiConcept, Paris, France Electronic address
    Vaccine 33:2813-22. 2015
    ..Influenza A(H3N2) and A(H1N1)pdm09 viruses co-circulated during the season...
  2. ncbi Early estimates of seasonal influenza vaccine effectiveness in Europe: results from the I-MOVE multicentre case-control study, 2012/13
    M Valenciano
    EpiConcept, Paris, France
    Euro Surveill 18:3. 2013
    ..4% (95% CI: -20.7 to 79.6) against all influenza types in the target groups for vaccination. Efforts to improve influenza vaccines should continue to better protect those at risk of severe illness or complications...
  3. doi Study designs for timely estimation of influenza vaccine effectiveness using European sentinel practitioner networks
    Marta Valenciano
    EpiConcept, Paris, France
    Vaccine 28:7381-8. 2010
    ..Results from practitioner-based studies complement other pieces of evidence (e.g. immunogenicity studies, vaccine efficacy, surveillance data) to assess the effect of influenza vaccination in the population...
  4. pmc Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-2010: results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) multicentre case-control study
    Marta Valenciano
    EpiConcept, Paris, France
    PLoS Med 8:e1000388. 2011
    ....
  5. pmc I-MOVE multi-centre case control study 2010-11: overall and stratified estimates of influenza vaccine effectiveness in Europe
    Esther Kissling
    EpiConcept, Paris, France
    PLoS ONE 6:e27622. 2011
    ....